Lux Health Tech Acquisition Corp.

Lux Health Tech Acquisition Corp.

LUXAU
Lux Health Tech Acquisition Corp.US flagNASDAQ Capital Market
10.02
USD
-0.01
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Financial Services
Industry
Shell Companies
Address
920 Broadway New York City NY United States of America 10010
IPO Date
Oct 27, 2020
Business
Lux Health Tech Acquisition Corp. Lux Health Tech Acquisition Corp. is a blank check company whose principal business activity is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company does not have significant operations or generate revenues; it focuses exclusively on identifying and pursuing targets at the intersection of the healthcare and technology industries. Incorporated in 2020, it is headquartered at 920 Broadway, 11th Floor, New York, New York. The company offers no core products or services beyond its structure as a special purpose acquisition company (SPAC), with activities limited to seeking, negotiating and completing a business combination within a typical 24-month tenor following its initial public offering. Lux Health Tech Acquisition Corp. priced its initial public offering in October 2020, raising approximately $345 million in proceeds held in trust, underwritten by Credit Suisse as left lead. It failed to identify or complete a business combination within the required timeframe and announced the cancellation of a special stockholder meeting in October 2022, followed by full liquidation and redemption of shares shortly thereafter. The company's securities, including units (LUXAU), Class A shares (LUXA) and warrants (LUXAW), ceased active trading and were delisted or marked as inactive, with no subsequent mergers, acquisitions, funding rounds or strategic shifts reported.